Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Evotaz (atazanavir and cobicistat) for the Treatment of HIV-1 Infection

Drug Name (Brand / Generic)

Evotaz / atazanavir and cobicistat

Company / Licensee

Bristol-Myers Squibb (BMS) / Gilead Sciences

Therapy Class

Protease inhibitor

Current Indication

HIV-1 infection

Market Sector

Anti-infectives

Development Status

Approved in the US and Europe
Expand

Go Top